Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Weikel, W
Lymphonodektomie beim Vulvakarzinom: Wann und wie vorgehen?Frauenheilkunde up2date. Bd. 13. H. 4. 2019 S. 355-365
Heesen, Ludwig; Frenzel, Katrin; Bolte, Stefanie et al.
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)CANCER RESEARCH. Bd. 79. H. 13. 2019
Hasenburg, A.
Neoadjuvant Chemotherapy for Ovarian Cancer?GYNAKOLOGE. Bd. 52. H. 9. 2019 S. 638-638
Hasenburg, A.
Ovarian Cancer Recurrence: Antiangiogenesis delays ProgressionGYNAKOLOGE. Bd. 52. H. 9. 2019 S. 638-638
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionUntch, Harbeck, Thomssen (Hrsg). Colloquium Senologie 2019/2020. München: LUKON Verlagsgesellschaft mbH 2019
Nabieva, Naiba; Haeberle, Lothar; Brucker, Sara Y. et al.
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patientsINTERNATIONAL JOURNAL OF CANCER. Bd. 145. H. 8. 2019 S. 2114-2121
Schneider, Mara; Winter, Julia; Poplawska, Krystyna et al.
Pregnancy and Maternal Chemotherapy - Side Effects for the Child?GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 79. H. 11. 2019 S. 1164-1167
Bauer, Heide-Katharina; Flesch, Daniela; Walenta, Stefan et al.
Primary Mucosal Epithelial Cell Cultivation: A Reliable and Accelerated IsolationTISSUE ENGINEERING PART C-METHODS. Bd. 25. H. 2. 2019 S. 82-92
Stergiou, Natascha; Gaidzik, Nikola; Heimes, Anne-Sophie et al.
Reduced Breast Tumor Growth after Immunization with a Tumor-Restricted MUC1 Glycopeptide Conjugated to Tetanus ToxoidCANCER IMMUNOLOGY RESEARCH. Bd. 7. H. 1. 2019 S. 113-122
Nezi-Cahn, Sandra; Sicking, Isabel; Almstedt, Kathrin et al.
Risk Factors for Chemotherapy-Associated Venous Thromboses in Gynaecological Oncology PatientsGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 79. H. 10. 2019 S. 1100-1109